Researcher.Life Logo

Clinical and Translational Imaging : Impact Factor & More

eISSN: 2281-7565pISSN: 2281-5872

Key Metrics

CiteScore
3.1
H-Index
32
Impact Factor
< 5
SJR
Q3Radiology, Nuclear Medicine and Imaging
SNIP
0.56
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Clinical and Translational Imaging

Clinical and Translational Imaging Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher SPRINGER-VERLAG ITALIA SRL
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2013
Website URLVisit website
View less

Planning to publish in Clinical and Translational Imaging ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Clinical and Translational Imaging

Joint survey by AIMN, AIOM, AIRO, SIU, SIUrO, and Meet-URO about the use of PSMA PET imaging in prostate cancer in Italy: PSA persistence, biochemical recurrence, hormone-sensitive and castration-resistant metastatic settings
  • 14 Apr 2026
  • Clinical and Translational Imaging
Radiomics in preclinical imaging: current trends and future directions
  • 23 Mar 2026
  • Clinical and Translational Imaging
Predicting conversion from mild cognitive impairment to Alzheimer’s disease using [18F]FDG PET with deep learning and radiomics: a systematic review and meta-analysis
  • 16 Mar 2026
  • Clinical and Translational Imaging
Comment on Zhou et al.: intrahepatic parathyroid adenoma localized with [18 F]Flurpiridaz and [68Ga]Ga-FAPI
  • 9 Mar 2026
  • Clinical and Translational Imaging
Feasibility of dynamic whole-body [⁶⁸Ga]Ga-PSMA-11 PET/CT Patlak parametric imaging for reducing bladder signal interference and improving lesion visualization
  • 4 Mar 2026
  • Clinical and Translational Imaging
Radiolabelled FAPI PET imaging in the era of immunotherapy: potential role in predicting tumour response and prognosis, and detecting immune-related adverse events – a short review
  • 24 Feb 2026
  • Clinical and Translational Imaging
Joint survey by AIMN, AIOM, AIRO, SIU, SIUrO, and Meet-URO about the use of PSMA PET imaging in prostate cancer in Italy: PSA persistence, biochemical recurrence, hormone-sensitive and castration-resistant metastatic settings
  • 14 Apr 2026
  • Clinical and Translational Imaging
Radiomics in preclinical imaging: current trends and future directions
  • 23 Mar 2026
  • Clinical and Translational Imaging
Predicting conversion from mild cognitive impairment to Alzheimer’s disease using [18F]FDG PET with deep learning and radiomics: a systematic review and meta-analysis
  • 16 Mar 2026
  • Clinical and Translational Imaging
Comment on Zhou et al.: intrahepatic parathyroid adenoma localized with [18 F]Flurpiridaz and [68Ga]Ga-FAPI
  • 9 Mar 2026
  • Clinical and Translational Imaging
Feasibility of dynamic whole-body [⁶⁸Ga]Ga-PSMA-11 PET/CT Patlak parametric imaging for reducing bladder signal interference and improving lesion visualization
  • 4 Mar 2026
  • Clinical and Translational Imaging
Radiolabelled FAPI PET imaging in the era of immunotherapy: potential role in predicting tumour response and prognosis, and detecting immune-related adverse events – a short review
  • 24 Feb 2026
  • Clinical and Translational Imaging

FAQs on Clinical and Translational Imaging